Finance

A collection of 311 posts

AI Featured

Did One Hacker and an AI Agent Just Breach South Korea's Biggest Banks?

AI agents breached four of South Korea's largest banks within days. The forensics point to a lone operator and a free open-source tool - and a new cost curve for cybercrime that markets haven't priced.

Members only

Finance Featured

American Express Missed $13 Billion in Suspected Dirty Money. The Stock Went Up.

The OCC fined Amex $350 million for a decade of AML failures — including insider-linked transactions. The market bought the stock anyway. What it saw in the fine print, and the look-back clause it's not pricing.

Macro Featured

The Consumer Is Fine. The Data Says Otherwise.

Credit card delinquencies just hit their lowest since 2023. Auto loan defaults just blew past their 2008 crisis peak. Both numbers are real — and together they reveal a consumer economy split cleanly in two.

Paid-members only

Markets Featured

$HUM: Humana Just Won Back the Star Rating It Sued Washington Over. The Market Repriced 2028 Overnight

Humana flipped 95% of its Medicare Advantage members into 4-star-plus plans for 2027, recovering the H5216 contract it sued CMS over and could not win back in court. The stock jumped ~14% premarket. We price the quality-bonus math, the Clover recalculation, and all three scenario zones.

Paid-members only

Markets Featured

Novo Nordisk Invented the Obesity Trade. The Market Just Priced It for Losing.

Eli Lilly is worth more than $1 trillion. Novo Nordisk trades near its 52-week low with an FDA decision on CagriSema due before year-end. Inside the pill war that split the obesity trade in two — and the catalyst that could reset it.

Paid-members only

Markets Featured

$WOLF: The Pentagon Offered Wolfspeed $1.5 Billion. The Market Bought the Headline; the Filing Sells a Process

Wolfspeed surged 20%+ on a conditional $1.5B, 30-year Department of War loan commitment, one year out of Chapter 11. We price the conditions chain, the 7.5% warrant dilution, the Renesas overhang, and the three scenario zones from here.

Macro Featured

The Bond Market Just Demoted France

French 10-year yields touched 5% for the first time since 2002, the euro is at a 17-month low, and France now borrows at higher rates than Italy. How the eurozone's second economy lost the benefit of the doubt — and why it matters for your money.

Paid-members only

Markets Featured

GTA VI Is 44 Days Away. The Market Keeps Selling the Company That Owns It.

Take-Two is six weeks from the biggest entertainment launch ever recorded, with pre-orders management calls unprecedented — and a stock down 20% from its July high. Somebody on this trade is wrong.

Paid-members only

Markets Featured

$BEAT: HeartBeam Traded Its Share Count Seven Times Over on an FDA Badge That Clears Nothing. Pricing the Breakthrough

HeartBeam spiked as much as 119% on an FDA Breakthrough Device Designation for at-home heart attack detection. The indication is not cleared, a $25M ATM equals two-thirds of the market cap, and Nasdaq's clock runs out December 28. We priced all four paths.

Paid-members only

Markets Featured

$PCVX: Vaxcyte Just Swept the Year's Biggest Vaccine Readout. Pricing the 53% Premarket Repricing

VAX-31 met every primary endpoint in its pivotal adult Phase 3 against Prevnar 20 and Capvaxive, and the stock gapped to a record. The share math, the serotype 3 fine print, the cash clock, and scenario zones for all four paths from here.

Macro Featured

The Most Expensive Open Enrollment in 20 Years Starts November 1

Employer health costs are set for their biggest jump since 2003, ACA insurers want a median 15% more, and the subsidies that cushioned the marketplace are gone. America's next inflation shock is in the benefits packet.

Members only

Markets Featured

America's Accidental Cannabis Market Has 68 Days to Live

A 2018 farm-bill loophole built a $28 billion intoxicating-hemp market sold in gas stations nationwide. Congress closed it, the deadline is December 11 — and the fight over who inherits the shelf space is already underway.

Macro Featured

America Stopped Hiring. The Fed Is Still Hiking.

29,000 jobs in September. July revised to a net loss. The Fed hiked into a frozen labor market and claimed job gains were keeping pace. What the freeze means for rates, wages, and your money.

Paid-members only

Finance Featured

The SEC Just Told Every Money Manager in America How to Hold Crypto

The SEC's new custody proposal gives America's $176.8 trillion adviser industry its first compliant path to holding crypto. The market shrugged. The custody toll-takers are the trade.

Members only

Finance Featured

The Slow-Motion Run on Private Credit

Blackstone's flagship retail credit fund has gated withdrawals two quarters running, Blue Owl is liquidating a fund outright, and the public market is pricing identical loans anywhere from par to 72 cents. The dispersion is the trade.

Paid-members only

Markets Featured

$MAT: A $20 Whisper for a $12 Stock. Pricing the Authentic Brands Approach to Mattel

Mattel jumped 19% on a reported $20-per-share takeover approach from Authentic Brands, one day after losing its CEO. The share math, the buyer's financing problem, and scenario-by-scenario price zones.

Markets Featured

By Tuesday, One Company Will Own Batman, Harry Potter, and SpongeBob

A federal judge just cleared the ~$110 billion Paramount-Warner Bros. Discovery merger to close October 6 — here is what the new Hollywood giant promised the states, who runs it, and the $79 billion debt question investors should watch.

Paid-members only

Markets Featured

$LQDA: Two Patent Claims Cut Liquidia in Half. The Remedy Ruling Lands Within a Week

Liquidia fell 57% after a Delaware court found YUTREPIA infringes two United Therapeutics patent claims covering PH-ILD, a patent that runs to 2042. Remedy proposals are due within a week. The revenue math, the damages overhang, the appeal precedent, and the scenario zones.

Paid-members only

Markets Featured

$CAPR: The FDA's Advisers Voted 9-3 Against Capricor's Duchenne Therapy. The Agency Kept Reviewing Anyway. 53 Days to the Answer

Capricor lost 80% of its value in five sessions after a 9-3 advisory vote against deramiocel. Then the FDA accepted a refined upper-limb indication and set a November 22 decision date. The trial math, the $4 cash floor, the $180 million voucher nobody prices, and the scenario zones.

Paid-members only

Finance Featured

Why America Is Buying Yen

The US Treasury intervened to strengthen the yen for the first time since 1998, the BOJ just hiked to a 31-year high, and Japan's entire bond curve trades at mid-1990s levels. The world's largest creditor is repricing — here's what it means for Treasuries, the carry trade, and your positioning.

Paid-members only

Markets Featured

$SMMT: AstraZeneca Just Paid a 19% Premium for a Piece of Summit. The FDA Decides What It's Worth in 46 Days

A $2 billion AstraZeneca check at $18.36 erased Summit's going-concern doubt overnight. Now ivonescimab faces a November 14 FDA decision built on a trial that hit progression-free survival and missed overall survival. The deal mechanics, the data ledger, and the scenario zones.

Macro Featured

Americans Feel Worse Than They Did in 2008. They Haven't Stopped Spending.

Consumer sentiment just printed the second-lowest reading in its 74-year history while retail sales grow 6% a year and the Fed hikes into the gloom. One of these signals is wrong — and which one breaks decides Q4.

Paid-members only

Markets Featured

$KOD: Kodiak's Left-for-Dead Eye Drug Just Passed Its Pivotal Trial, and the Stock Gapped 70% Before the Open

Kodiak's DAYBREAK Phase 3 hit on both drugs, with six-month dosing under the strictest retreatment rules yet used in wet AMD. Behind the 70% gap: a $126M cash pile, a near-certain raise, and the number the topline release left out.

Paid-members only

Markets Featured

One Hack Shut a National Champion for Five Weeks. The Repricing Is Just Starting.

The Jaguar Land Rover attack cost the UK economy an estimated £1.9 billion and hit 5,000 suppliers. Ransomware just became a macro risk — and the capital is starting to move.

Members only

Finance Featured

America's Banks Passed a Stress Test for the Wrong Stress

All 32 big banks passed a Fed scenario where the 10-year Treasury falls to 2.3%. It closed Friday at 5.18% — and Washington is weeks from finalizing rules that make the test easier to predict. The $327 billion problem hides in plain sight.